We really enjoyed this discussion with Dylan Sherry about his article (citation below) discussing buprenorphine as first line management for cancer related pain. I forgot to start recording until partway into the lecture, but the subsequent discussion is rousing. Click on Dr. Sherry’s picture to view the recording.

Chwistek, M., Sherry, D., Kinczewski, L., Silveira, M. J., & Davis, M. (2023). Should Buprenorphine Be Considered a First-Line Opioid for the Treatment of Moderate to Severe Cancer Pain?. Journal of pain and symptom management, S0885-3924(23)00566-3. Advance online publication. https://doi.org/10.1016/j.jpainsymman.2023